PacBio Announces Second Quarter 2023 Financial Results

/PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2023. Second quarter results Revenue of $47.6 million, a...

Related Keywords

California ,United States ,Germany ,Pacific Biosciences ,Lizelda Lopez ,Todd Friedman ,Jay Shendure ,Christian Henry ,California Inc ,Nasdaq ,Radboud University Medical Center Radboudumc ,Professor Of Genome Sciences ,Securities Exchange ,University Of Washington ,Apton Biosystems Inc ,Exchange Commission ,Apton Biosystems ,Radboud University Medical Center ,Computer Science ,Lewis Sigler Institute ,Integrative Genomics ,Princeton University ,Scientific Advisory Board ,Genome Sciences ,Convertible Senior Notes ,Chief Executive ,Securities Exchange Act ,Securities Litigation Reform Act ,Quarterly Report ,Condensed Consolidated Statement ,Convertible Senior ,Pacific Biosciences Of California ,Nc ,